Focus
genetic risk
FDA Approves the First Test to Identify Risk of Opioid Addiction
The AvertD test uses a cheek swab to identify markers of potential opioid addiction.
|
FDA Approves the First Test to Identify Risk of Opioid Addiction
The AvertD test uses a cheek swab to identify markers of potential opioid addiction.
|